CDKN2B-AS1: An indispensable long non-coding RNA in multiple diseases.
CONCLUSIONS: Long non-coding RNA CDKN2B-AS1 likely serves as a promising therapeutic target or prognosis biomarker in multiple human diseases.
PMID: 32767927 [PubMed - as supplied by publisher]
Source: Current Pharmaceutical Design - Category: Drugs & Pharmacology Authors: Song C, Qi Y, Zhang J, Guo C, Yuan C Tags: Curr Pharm Des Source Type: research
More News: Adenocarcinoma | Bile Duct Cancer | Bone Cancers | Brain Tumor | Breast Cancer | Breast Carcinoma | Cancer | Cancer & Oncology | Carbohydrates | Carcinoma | Cardiology | Cervical Cancer | Cholangiocarcinoma | Databases & Libraries | Diabetes | Diabetes Mellitus | Drugs & Pharmacology | Endocrinology | Endometriosis | Esophagus Cancer | Gastric (Stomach) Cancer | Gastroenterology | Glaucoma | Glioma | Heart | Heart Failure | Hepatocellular Carcinoma | Hypertension | Inflammatory Bowel Disease | Ischemic Stroke | Laryngeal Cancer | Liver Cancer | Lung Cancer | Molecular Biology | Osteosarcoma | Ovarian Cancer | Ovaries | Skin Cancer | Squamous Cell Carcinoma | Stroke | Study
MedWorm Privacy Policy
Disclaimer
Copyright © MedWorm 2006-2024